Palopegteriparatide

ATC H05AA05 · 5 markets · 14 records

Palopegteriparatide 5 markets · 14 records Forms

AU 4 records · 2 strengths

0.3 mg/mLinjectionYORVIPATH palopegteriparatide 168 micrograms / 0.56 mL solution for injection in multidose pre-filled pen+2YORVIPATH palopegteriparatide 294 micrograms / 0.98 mL solution for injection in multidose pre-filled pen、YORVIPATH palopegteriparatide 420 micrograms / 1.4 mL solution for injection in multidose pre-filled pen unknown

Records without a stated strength · 1 Yorvipath

US 3 records · 3 strengths

0.42 mg/1.4 mLinjectionYorvipath
0.294 mg/0.98 mLinjectionYorvipath
0.168 mg/0.56 mLinjectionYorvipath

GB 3 records · 3 strengths

1.4 mLinjectionYorvipath 420micrograms/1.4ml solution for injection pre-filled pens
0.98 mLinjectionYorvipath 294micrograms/0.98ml solution for injection pre-filled pens
0.56 mLinjectionYorvipath 168micrograms/0.56ml solution for injection pre-filled pens

CA 3 records · 3 strengths

0.3 mg/1 mLliquidYorvipath
0.294 mgliquidYorvipath
0.168 mgliquidYorvipath

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Yorvipath

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.